Tim M. Mayleben
2011 - Vericel
In 2011, Tim M. Mayleben earned a total compensation of $1.7M as Former President and CEO at Vericel.
Compensation breakdown
| Bonus | $23,750 |
|---|---|
| Non-Equity Incentive Plan | $191,250 |
| Option Awards | $1,055,130 |
| Salary | $425,000 |
| Other | $11,356 |
| Total | $1,706,486 |
Mayleben received $1.1M in option awards, accounting for 62% of the total pay in 2011.
Mayleben also received $23.8K in bonus, $191.3K in non-equity incentive plan, $425K in salary and $11.4K in other compensation.
Rankings
In 2011, Tim M. Mayleben's compensation ranked 3,790th out of 10,747 executives tracked by ExecPay. In other words, Mayleben earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,790 out of 10,747 | 65th |
Division Manufacturing | 1,329 out of 3,960 | 66th |
Major group Chemicals And Allied Products | 264 out of 1,033 | 74th |
Industry group Drugs | 152 out of 781 | 81st |
Industry Biological Products, Except Diagnostic Substances | 19 out of 157 | 88th |
Source: SEC filing on October 21, 2014.
Mayleben's colleagues
We found three more compensation records of executives who worked with Tim M. Mayleben at Vericel in 2011.
News
Landos Biopharma CEO Gregory Oakes receives $1.8M in 2022
April 19, 2023
Landos Biopharma Executive Vice President of Operations Jyoti RAC's 2021 pay jumps 195% to $2.8M
April 28, 2022
Esperion Therapeutics CEO Tim Mayleben's 2021 pay rises 19% to $8.2M
April 14, 2022
Esperion Therapeutics CEO Tim Mayleben's 2019 pay falls 89% to $1.1M
April 16, 2020
Esperion Therapeutics CEO Tim Mayleben's 2018 pay jumps 94% to $9.7M
April 18, 2019